OSD

Improving the bioavailability of drug formulations is a key focus during drug development, as is the need to create patient centric drug products that are convenient to take.

Innovation in formulation development continues to be driven by the need to improve drug bioavailability.

In an article in Contract Pharma, Recipharm’s General Manager Pharmaceutical Development, Torkel Gren, explores the hurdles that must be overcome during early phase drug development such as bioavailability and stability challenges, the rise in inhalation drugs and the growing market for fixed dose drug combination (FDC) products.

Read the full article here Formulation Development Trends